Serological biomarkers for management of primary sclerosing cholangitisDávid Tornai, Mária Papp, Peter Laszlo Ven et al.|World Journal of Gastroenterology|2022Cited by 24
Longitudinal Comparison of Currently Used Risk Scores for Prognostication of Primary Sclerosing Cholangitis (PSC) in a Hungarian Bicenter PSC CohortPeter Laszlo Ven, Mária Papp, Tamás Tornai et al.|Diagnostics|2025Cited by 2
P0443 Prognosis of primary sclerosing cholangitis (PSC) in Hungary is independent of coexisting inflammatory bowel disease (IBD) and prognostic ability of the currently used PSC risk scores are limitedPeter Laszlo Ven, Mária Papp, I Altorjay et al.|Journal of Crohn s and Colitis|2025Cited by 0
THU-367 Prognosis of primary sclerosing cholangitis (PSC) in Hungary is independent of coexisting inflammatory bowel disease (IBD) and prognostic ability of the currently used PSC risk scores are limitedDávid Tornai, Mária Papp, Peter Laszlo Ven et al.|Journal of Hepatology|2025Cited by 0